INmune Bio News

Analysts Offer Insights on Healthcare Companies: Inmune Bio (INMB), Insmed (INSM) and Tenet Healthcare (THC)

TipRanksMay 14 07:50 ET

Robust Pipeline and Financial Stability Underpin Buy Rating for Inmune Bio

TipRanksMay 11 12:35 ET

Inmune Bio's Promising INKmune Therapy and Strong Financials Merit a Buy Rating

TipRanksApr 30 13:45 ET

Inmune Bio Earns Buy Rating on Positive XPro Developments and Strong Financials

TipRanksApr 25 12:55 ET

Inmune Bio's INB03 Shows Promise as Pan-Immune Checkpoint Inhibitor: A Buy Rating From Analyst Joel Beatty

TipRanksApr 12 01:35 ET

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV) and Inmune Bio (INMB)

TipRanksApr 2 16:10 ET

Buy Rating Affirmed for Inmune Bio Amid Promising Alzheimer's Treatment Developments

TipRanksMar 6 13:56 ET

BTIG Remains a Buy on Inmune Bio (INMB)

TipRanksFeb 2 05:25 ET

Buy Rating Affirmed: Inmune Bio's XPro Progresses With FDA's Green Light and Unique Therapeutic Approach

TipRanksFeb 1 00:37 ET

Inmune Bio's Buy Rating Affirmed Amid Positive Alzheimer's Program Developments

TipRanksJan 31 12:35 ET

Buy Rating Affirmed for INmune Bio Amid Progress in Cancer Therapy Trials and Financial Stability

TipRanksJan 3 12:36 ET

Analysts Offer Insights on Healthcare Companies: Inmune Bio (INMB) and Idexx Laboratories (IDXX)

TipRanksDec 20, 2023 06:00 ET

Buy Rating for Inmune Bio Backed by Promising Therapeutic Developments and Regulatory Progress

TipRanksNov 30, 2023 14:55 ET

Buy Rating on Inmune Bio: Expansion and Promising Developments in Alzheimer's Treatment Trials

TipRanksNov 27, 2023 13:45 ET

Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Inmune Bio (INMB) and Guardant Health (GH)

TipRanksNov 15, 2023 20:30 ET

Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Universal Health (UHS) and Inmune Bio (INMB)

TipRanksOct 30, 2023 06:10 ET

Inmune Bio (INMB) Receives a Buy From BTIG

TipRanksSep 6, 2023 03:15 ET

Inmune Bio (INMB) Receives a Buy From Robert W. Baird

TipRanksAug 11, 2023 12:16 ET

Analysts' Top Healthcare Picks: Seres Therapeutics (MCRB), Inmune Bio (INMB)

TipRanksAug 9, 2023 07:50 ET

Maxim Group Sticks to Its Buy Rating for Inmune Bio (INMB)

TipRanksJul 29, 2023 07:35 ET